Utilizing an Integrated, Multi-Channel Approach Can Improve Access for Oncology Products
Published: | Updated:
How biopharma companies can pursue multiple channels to enhance access to segmented markets.
Brand Insights - Thought Leadership | Paid Program | McKesson Life Sciences
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: FDA Approves Hernexeos
2
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
FDA Approves Dupixent as First Treatment for Allergic Fungal Rhinosinusitis in Adults and Children
5